MX365914B - Forma de dosificación de topiramato dispersable rápidamente. - Google Patents
Forma de dosificación de topiramato dispersable rápidamente.Info
- Publication number
- MX365914B MX365914B MX2015012135A MX2015012135A MX365914B MX 365914 B MX365914 B MX 365914B MX 2015012135 A MX2015012135 A MX 2015012135A MX 2015012135 A MX2015012135 A MX 2015012135A MX 365914 B MX365914 B MX 365914B
- Authority
- MX
- Mexico
- Prior art keywords
- topiramate
- dosage form
- rapidly dispersible
- dispersible dosage
- taste
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporciona una forma de dosificación dispersable rápidamente de sabor enmascarado de topiramato. Las partículas revestidas con cera de topiramato se incluyen dentro de una matriz unida porosa. El topiramato retiene su forma de sabor enmascarado después de la dispersión en la boca de un sujeto aunque las partículas no estén revestidas con un material polimérico. La forma de dosificación se dispersa en la saliva o agua en menos de 2 minutos aunque tenga un alto contenido de cera. Se puede utilizar para tratar enfermedades o trastornos que son sensibles terapéuticamente al topiramato o un derivado del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361791592P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/029168 WO2014144661A1 (en) | 2013-03-15 | 2014-03-14 | Rapidly dispersible dosage form of topiramate |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015012135A MX2015012135A (es) | 2015-11-25 |
MX365914B true MX365914B (es) | 2019-06-20 |
Family
ID=51537752
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015012135A MX365914B (es) | 2013-03-15 | 2014-03-14 | Forma de dosificación de topiramato dispersable rápidamente. |
Country Status (10)
Country | Link |
---|---|
US (2) | US9492380B2 (es) |
EP (1) | EP2968181B1 (es) |
JP (1) | JP6466399B2 (es) |
CN (1) | CN105050588B (es) |
AU (2) | AU2014228861B2 (es) |
CA (1) | CA2906172C (es) |
ES (1) | ES2761407T3 (es) |
HK (2) | HK1213473A1 (es) |
MX (1) | MX365914B (es) |
WO (1) | WO2014144661A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2696341C (en) * | 2007-08-13 | 2016-05-17 | Abuse Deterrent Pharmaceutical Llc | Abuse resistant drugs, method of use and method of making |
US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
CN104586871B (zh) * | 2014-12-27 | 2018-01-16 | 北京罗诺强施医药技术研发中心有限公司 | 包含托吡酯的药物组合物 |
US20160243036A1 (en) * | 2015-02-25 | 2016-08-25 | Intelgenx Corp. | Film dosage forms containing amorphous active agents |
AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
WO2017175792A1 (ja) * | 2016-04-06 | 2017-10-12 | アステラス製薬株式会社 | 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料 |
BR112019003432A2 (pt) | 2016-09-02 | 2019-05-21 | Novo Futura Ivs | churrasqueira descartável, bandeja descartável, e método de fabricação de churrasqueiras |
CN107252418B (zh) * | 2017-05-17 | 2020-06-23 | 西安棣加生物科技有限公司 | 一种3d打印技术制备治疗低钾血症的口腔速崩片的方法 |
CN107213126B (zh) * | 2017-05-17 | 2020-06-23 | 西安棣加生物科技有限公司 | 一种3d打印技术制备治疗高磷血症的口腔速崩片的方法 |
US10703549B2 (en) * | 2017-06-30 | 2020-07-07 | The Procter And Gamble Company | Water soluble containers and methods of making them |
MX2020004403A (es) * | 2017-11-02 | 2020-08-06 | Zambon Spa | Composiciones farmaceuticas que comprenden safinamida. |
JP7360949B2 (ja) * | 2017-12-26 | 2023-10-13 | 東和薬品株式会社 | 環状口腔内崩壊錠 |
CN116270513A (zh) | 2018-01-09 | 2023-06-23 | 南京三迭纪医药科技有限公司 | 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型 |
CN112218617A (zh) * | 2018-04-10 | 2021-01-12 | 潘纳西亚比奥马特斯公司 | 利用附加制造技术制备个性化营养配方和药物配方的方法和系统 |
CA3112618A1 (en) * | 2018-09-14 | 2020-03-19 | Merck Patent Gmbh | Process for the preparation of a coated solid pharmaceutical dosage form |
JP2022508714A (ja) * | 2018-10-15 | 2022-01-19 | アプレシア・ファーマスーティカルズ・エルエルシー | 包装内に剤形を形成する方法およびシステム |
US20220016074A1 (en) * | 2018-11-21 | 2022-01-20 | Rosemont Pharmaceuticals Limited | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
MX2021009679A (es) | 2019-02-22 | 2021-09-10 | Catalent Uk Swindon Zydis Ltd | Minimizacion de aglomeracion, aireacion y conservacion del revestimiento de composiciones farmaceuticas que comprenden ibuprofeno. |
MX2021009844A (es) | 2019-02-22 | 2021-09-10 | Catalent Uk Swindon Zydis Ltd | Conservacion de particulas de ingredientes farmaceuticos activos revestidas funcionalmente producidas mediante procesos de mezcla sin solvente en suspension acuosa. |
AU2020225448A1 (en) * | 2019-02-22 | 2021-10-14 | Catalent U.K. Swindon Zydis Limited | Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products |
CN114364260A (zh) * | 2019-09-13 | 2022-04-15 | 株式会社明治 | 固体食品和固体奶 |
JP2023533478A (ja) | 2020-06-26 | 2023-08-03 | アプレシア・ファーマスーティカルズ・エルエルシー | 内部空洞を有する迅速口内分散可能な錠剤 |
WO2024108082A1 (en) | 2022-11-18 | 2024-05-23 | Aprecia Pharmaceuticals LLC | Orodispersive dosage forms containing droxidopa |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
US4513006A (en) | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
EP0418596A3 (en) | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
DE4200821A1 (de) | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
CA2166891C (en) | 1993-07-09 | 2001-07-03 | Sang K. Wong | Method for making freeze dried drug dosage forms |
US5490962A (en) * | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
GB9421837D0 (en) | 1994-10-28 | 1994-12-14 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms |
US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
AU736912B2 (en) | 1997-02-20 | 2001-08-02 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
KR100675809B1 (ko) | 1999-07-09 | 2007-02-01 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 맛을 차폐시킨 약제학적 액체 제제 |
AP2002002410A0 (en) * | 1999-08-04 | 2002-03-31 | Ranbaxy Laboratories Ltd | Hydrodynamically Balancing Oral Drug Delivery System |
DE19940944B4 (de) | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
ATE315930T1 (de) * | 2000-05-18 | 2006-02-15 | Therics Inc | Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform |
WO2003097018A1 (en) * | 2002-02-04 | 2003-11-27 | Ranbaxy Laboratories Limited | Hydrodynamically balancing oral drug delivery system with biphasic release |
CA2440069A1 (en) | 2001-03-05 | 2002-09-12 | Ortho-Mcneil Pharmaceutical, Inc. | Taste masked pharmaceutical compositions |
ATE322972T1 (de) * | 2001-10-29 | 2006-04-15 | Therics Inc | System und verfahren zum uniaxialen pressen eines gegenstandes wie eine drei-dimensional gedruckte dosierungsform |
JP2005509001A (ja) * | 2001-10-29 | 2005-04-07 | セリクス, インコーポレイテッド | 投薬形態の三次元懸濁液プリンティング |
FR2838647B1 (fr) | 2002-04-23 | 2006-02-17 | Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant | |
US20060039981A1 (en) * | 2002-09-04 | 2006-02-23 | Deepak Murpani | Taste masked dosage forms and processes for their preparation |
US20060159758A1 (en) | 2002-12-11 | 2006-07-20 | Rajesh Gandhi | Coating composition for taste masking coating and methods for their application and use |
NZ544007A (en) | 2003-05-07 | 2009-05-31 | Samyang Corp | Highly plastic granules for making fast melting tablets |
FR2858556B1 (fr) | 2003-08-06 | 2006-03-10 | Galenix Innovations | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation |
BRPI0413881A (pt) | 2003-08-28 | 2006-10-24 | Sandoz Ag | composição farmacêutica compreendendo anticonvulsivante com revestimento de mascaramento de gosto |
CA2551825A1 (en) * | 2003-12-29 | 2005-07-21 | David Edgren | Drug granule coatings that impart smear resistance during mechanical compression |
EP1771159A4 (en) * | 2004-07-22 | 2009-04-29 | Amorepacific Corp | SLOW RELEASE PREPARATIONS CONTAINING TOPIRAMATE AND PROCESS FOR PRODUCING THE SAME |
US20060127479A1 (en) | 2004-10-08 | 2006-06-15 | Natrajan Kumaraperumal | Solvent free taste masked pharmaceutical compositions |
US20060182796A1 (en) | 2005-02-03 | 2006-08-17 | Abrika Pharmaceuticals, Inc. | Taste masked pharmaceutical compositions |
US20070092553A1 (en) | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
WO2008027557A2 (en) * | 2006-08-31 | 2008-03-06 | Spherics, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
CN101553204B (zh) * | 2006-12-04 | 2013-10-30 | 苏佩努斯制药公司 | 托吡酯的增强的立即释放制剂 |
CA2704209C (en) * | 2007-10-31 | 2017-02-28 | Mcneil-Ppc, Inc. | Orally disintegrative dosage form |
WO2009106824A2 (en) * | 2008-02-25 | 2009-09-03 | Cipla Limited | Pharmaceutical formulations |
WO2010092828A1 (ja) | 2009-02-12 | 2010-08-19 | 富士化学工業株式会社 | 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物 |
US20100285130A1 (en) | 2009-05-06 | 2010-11-11 | Monosol Rx, Llc | Coating of complexed actives in film formulations |
EP2437734A2 (de) | 2009-06-04 | 2012-04-11 | Basf Se | Oral zerfallende dosierungsformen enthaltend geschmacksmaskierte wirkstoffe |
KR20120056824A (ko) * | 2009-08-19 | 2012-06-04 | 바이엘 파마 악티엔게젤샤프트 | 소아과 용도를 위한 약물 전달 시스템 (웨이퍼) |
TW201127375A (en) * | 2010-01-08 | 2011-08-16 | Eurand Inc | Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
JP6133009B2 (ja) * | 2010-08-11 | 2017-05-24 | 協和発酵キリン株式会社 | トピラマート顆粒 |
US9381154B2 (en) * | 2011-06-09 | 2016-07-05 | Xerox Corporation | Direct inkjet fabrication of drug delivery devices |
-
2014
- 2014-03-14 AU AU2014228861A patent/AU2014228861B2/en active Active
- 2014-03-14 CA CA2906172A patent/CA2906172C/en active Active
- 2014-03-14 ES ES14763925T patent/ES2761407T3/es active Active
- 2014-03-14 MX MX2015012135A patent/MX365914B/es active IP Right Grant
- 2014-03-14 EP EP14763925.6A patent/EP2968181B1/en active Active
- 2014-03-14 WO PCT/US2014/029168 patent/WO2014144661A1/en active Application Filing
- 2014-03-14 CN CN201480015723.7A patent/CN105050588B/zh active Active
- 2014-03-14 JP JP2016503003A patent/JP6466399B2/ja active Active
-
2015
- 2015-08-27 US US14/837,354 patent/US9492380B2/en active Active
-
2016
- 2016-02-04 HK HK16101295.2A patent/HK1213473A1/zh unknown
- 2016-03-11 HK HK16102818.8A patent/HK1214768A1/zh unknown
- 2016-08-23 US US15/244,563 patent/US10420785B2/en active Active
-
2018
- 2018-08-22 AU AU2018220049A patent/AU2018220049B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2014144661A4 (en) | 2014-11-13 |
AU2014228861A1 (en) | 2015-10-08 |
AU2014228861B2 (en) | 2018-05-24 |
WO2014144661A1 (en) | 2014-09-18 |
HK1214768A1 (zh) | 2016-08-05 |
CA2906172C (en) | 2021-12-21 |
MX2015012135A (es) | 2015-11-25 |
CA2906172A1 (en) | 2014-09-18 |
AU2018220049A1 (en) | 2018-09-06 |
ES2761407T3 (es) | 2020-05-19 |
US9492380B2 (en) | 2016-11-15 |
HK1213473A1 (zh) | 2016-07-08 |
US20160361335A1 (en) | 2016-12-15 |
WO2014144661A8 (en) | 2015-08-27 |
EP2968181A1 (en) | 2016-01-20 |
JP2016514686A (ja) | 2016-05-23 |
JP6466399B2 (ja) | 2019-02-06 |
CN105050588A (zh) | 2015-11-11 |
US20150366801A1 (en) | 2015-12-24 |
US10420785B2 (en) | 2019-09-24 |
CN105050588B (zh) | 2019-01-15 |
EP2968181A4 (en) | 2016-04-13 |
AU2018220049B2 (en) | 2020-07-09 |
EP2968181B1 (en) | 2019-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015012135A (es) | Forma de dosificacion de topiramato dispersable rapidamente. | |
WO2011115725A3 (en) | Indazole compounds as kinase activity modulators for the treatment of cancer and related disorders | |
SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
EP3160493A4 (en) | Compositions and methods to regulate renalase in the treatment of diseases and disorders | |
PH12016500284B1 (en) | Oral care composition | |
MX2015012134A (es) | Forma de dosificacion de dispersion rapida que contiene levetiracetam. | |
TWD174792S (zh) | 端蓋 | |
MY184241A (en) | Human antibodies to gfr?3 and methods of use thereof | |
IL245429B (en) | A pharmaceutical preparation containing a derivative of glutarimide and its use in the treatment of eosinophilic diseases | |
WO2014184677A3 (en) | Eye care devices and methods | |
EP3403658C0 (en) | COMPOSITION FOR THE TREATMENT OF NEUROINFLAMMATORY DISEASES CONTAINING NEURAL STEM CELLS OR THEIR SECRETOME AS ACTIVE INGREDIENT | |
MX2015013254A (es) | Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas. | |
EP2976072A4 (en) | THIN PARTICLES OF EPINEPHRINE AND METHODS OF USE THEREOF FOR THE TREATMENT OF EPINEPHRINE-RELATING CONDITIONS | |
IL245738A0 (en) | Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases | |
MA55947A (fr) | Compositions pharmaceutiques et utilisations dirigées vers des troubles d'entreposage lysosomial | |
MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
SI2874600T1 (sl) | Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu | |
EP3558374A4 (en) | BIOPHOTONIC COMPOSITIONS CONSISTING OF LICHEN EXTRACT AND THEIR USE IN THE TREATMENT OF SKIN DISORDERS | |
JP2016535794A5 (ja) | 急速崩壊性固体剤形 | |
PH12017500763A1 (en) | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof | |
EA201600412A1 (ru) | Способ производства неорганического материала в виде частиц | |
FR2992219B1 (fr) | Composition pour le traitement de l'hypocalcemie chez les ruminants | |
EP3240562A4 (en) | Compositions and methods for delivering lypophilic agents to dental pulp and for enhancing dentin production | |
MX2018013569A (es) | Composicion valeriana y metodos relacionados. | |
ZA201507673B (en) | Phenylephrine resinate particles and use thereof in pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: APRECIA PHARMACEUTICALS LLC |
|
FG | Grant or registration |